Schizophrenia and Related Disorders During Mid- to Late-Life (R21 Clinical Trial Optional)
Key Information
Due Date: September 7, 2026
Agency: United States Department of Health and Human Services
Source: Federal
Website: View Website
Funding Categories:
Funding Amount: Not Specified
Funding Type: Grant
Match Required: No
Status: Posted
Contact Info:
grantsinfo@nih.gov
NIH Grants Information grantsinfo@nih.gov
NIH Grants Information grantsinfo@nih.gov
Overview
Although the majority living with schizophrenia and related disorders are over 35 years old, including those first diagnosed and those aging with the illness, the mechanisms underlying the generation and trajectory of the illness remain poorly understood. The purpose of this initiative is to advance translational research to better understand the emergence and trajectory of schizophrenia and related disorders in mid to late life, and to identity targets for future development of prevention and treatment efforts.
Show More
Additional Info
Posted Date: November 18, 2024
Application Due Date: September 7, 2026
Estimated Award Date: Not Specified
Eligible Applicants:
- For profit organizations other than small businesses
- County governments
- Small businesses
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- Native American tribal governments (Federally recognized)
- Others
- City or township governments
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- State governments
- Independent school districts
- Public and State controlled institutions of higher education
- Public housing authorities/Indian housing authorities
- Special district governments
- Native American tribal organizations (other than Federally recognized tribal governments)
Apply with Confidence
Our partners at Syncurrent help local governments move from searching to applying. Confirm eligibility, access funding documents, and begin building a complete application in a single secure platform.
